| Pharmaceutical Information |
| Drug Name |
Hydroxyprogesterone |
| Drug ID |
BADD_D01106 |
| Description |
Not Available |
| Indications and Usage |
Hydroxyprogesterone caproate is indicated for the prevention of spontaneous preterm births in singleton pregnancies in women who have previously had a spontaneous preterm birth. (1) |
| Marketing Status |
Not Available |
| ATC Code |
G03DA03 |
| DrugBank ID |
DB14570
|
| KEGG ID |
D08052
|
| MeSH ID |
D000077713
|
| PubChem ID |
6238
|
| TTD Drug ID |
D00AEQ
|
| NDC Product Code |
73309-243 |
| Synonyms |
17 alpha-Hydroxyprogesterone Caproate | 17 alpha Hydroxyprogesterone Caproate | 17-alpha-Hydroxy-Progesterone Caproate | 17 alpha Hydroxy Progesterone Caproate | Caproate, 17-alpha-Hydroxy-Progesterone | Oxyprogesterone Caproate | Hydroxyprogesterone Caproate | Hydroxyprogesterone Hexanoate | 17 alpha-Oxyprogesterone Capronate | 17 alpha Oxyprogesterone Capronate | 17-Hydroxyprogesterone Capronate | 17 Hydroxyprogesterone Capronate | Prolutin Depot | Proluton Depot | Neolutin | Makena | Delalutin |
|
| Chemical Information |
| Molecular Formula |
C21H30O3 |
| CAS Registry Number |
68-96-2 |
| SMILES |
CC(=O)C1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
